Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells. This medication is commonly prescribed for postmenopausal women.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to reduce the risk of cancer recurrence. The medication works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogen. This reduction in estrogen levels can help slow the growth of cancer cells that rely on estrogen to proliferate.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headache, or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication.

Femara should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be taken by pregnant women or those planning to become pregnant, as it can cause harm to a developing fetus.

Femara may interact with certain medications, including estrogen-containing therapies, tamoxifen, and other drugs that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while taking Femara, as it may exacerbate certain side effects.